- Email: [email protected]
Prostate Cancer: Biology, Genetics, and the New Therapeutics, 2nd Edition
BOOK REVIEWS Bibliographic Data: Blackwell Publishing, 2008, $169.95. ISBN: 978-1-4051-5112-2, NLM: WF 658, LC: RC280, 468 pages, hard cover. ISBN-10: 1405151129.
Prostate Cancer: Biology, Genetics, and the New Therapeutics, 2nd Edition
Description: This is the third edition of a book that broadly addresses all aspects of lung cancer, including epidemiology, biology, and diagnosis, with special emphasis on recent advances in management occurring during the past decade. It is significantly revised from the first edition published 10-14 years earlier. The compilation was edited by three well known academicians at the University of Texas M D Anderson Cancer Center – Jack A. Roth, MD, James D Cox, MD, and Waun Ki Hong, MD, with more than 60 contributors of international renown.
Editors: Chung, Leland WK, PhD; Isaacs, William B., PhD; Simons, Jonathan, MD Bibliographic Data: Humana Press Inc., 2007, $179.00. ISBN: 978-1-58829-696-2, NLM: WJ 762, LC: RC280, Series Title: Contemporary Cancer Research, 508 pages, hard cover. ISBN-10: 1588296962. Description: This book relates the latest knowledge and technology in translational research in prostate cancer. Purpose: It is a valuable reference and guide for any one working in translational prostate cancer research - and it is easy to read. Audience: This is a must read for those who are about to enter the field of translational research in prostate cancer, but it also serves as an excellent reference for established investigators. Features: The 26 chapters are divided into three parts: basic biology and imaging,genetics, and therapy. In part I, 13 chapters cover topics ranging from prostate cancer stem cells to bone metastasis and from androgen receptor functions to novel molecular signaling events. Of particular interest, the editors have selected practical technologies such as xenograft models, tissue microarrays, nanotechnologies, and modern noninvasive imaging techniques. As pointed out by the editors, in the post-human-genome era, much progress has been made in understanding the genetics of human prostate cancer. The five chapters in part II offer readers the latest information in genetic and epigenetic advances in this area. Part III devotes eight chapters to the most innovative ideas for treating patients with advanced prostate cancer. Although effective therapeutic strategies are not yet available for advanced prostate cancer, the Lance Armstrong effect described by Don Coffey in the foreword fits perfectly for this book. Assessment: It will be interesting to look back, say in 10 years, to see whether these chapters have paved the way for the development of new and efficacious therapeutic procedures for prostate cancer. Score: Weighted Numerical Score: 91 Reviewed by: Chung Lee, Ph.D. ( Northwestern University Feinberg School of Medicine)
Purpose: In aggregate, an attempt is made to adopt the observations of authorities from diverse experience, providing a comprehensive review of the current state of the art on bronchogenic carcinoma. Audience: The audience would include primarily pulmonologists, thoracic surgeons, oncologists, or those aspiring to these disciplines. Others would undoubtedly find the reference selectively informative. It would additionally provide a real-life reference for basic science researchers in putting a face on applications carried out in the laboratory. Features: The book covers the broad subject of bronchogenic carcinoma and augments substantially the presentation of the last edition. Although usually sufficient to carry out the ends of each chapter, the illustrations and graphics are quite limited and probably represent the most notable shortcoming of the book. The bibliographies at each chapter end are extensive and relevant. Assessment: The is one of the most comprehensive and up-to-date treatises that I have surveyed, yet it is remarkably simple and to the point, covering basic molecular biology and genetics underlying the disease for the clinician, as well as epidemiology, early diagnosis, clinical presentation, and management. It focuses exceptionally upon the speculated growing role for targeted therapies with more limited toxicities than historical treatments. The book achieves its likely intended goals well. For an average practitioner, it comes across as very reachable, but probably not a compelling read. I recommend the book highly to anyone in allied disciplines, and would personally consider it a practical resource to add to my personal library.
Lung Cancer, 3rd Edition
Score: Weighted Numerical Score: 88
Editors: Roth, Jack A., MD, FACS; Cox, James D., MD; Hong, Waun Ki, MD, DMSc
Reviewed by: Joel C Seidman, MD ( William Beaumont Hospitals)
© 2009 by the American College of Surgeons Published by Elsevier Inc.
e1
ISSN 1072-7515/09/$36.00 doi:10.1016/j.jamcollsurg.2008.07.014
Prostate Cancer: Biology, Genetics, and the New Therapeutics, 2nd Edition
Description: This is the third edition of a book that broadly addresses all aspects of lung cancer, including epidemiology, biology, and diagnosis, with special emphasis on recent advances in management occurring during the past decade. It is significantly revised from the first edition published 10-14 years earlier. The compilation was edited by three well known academicians at the University of Texas M D Anderson Cancer Center – Jack A. Roth, MD, James D Cox, MD, and Waun Ki Hong, MD, with more than 60 contributors of international renown.
Editors: Chung, Leland WK, PhD; Isaacs, William B., PhD; Simons, Jonathan, MD Bibliographic Data: Humana Press Inc., 2007, $179.00. ISBN: 978-1-58829-696-2, NLM: WJ 762, LC: RC280, Series Title: Contemporary Cancer Research, 508 pages, hard cover. ISBN-10: 1588296962. Description: This book relates the latest knowledge and technology in translational research in prostate cancer. Purpose: It is a valuable reference and guide for any one working in translational prostate cancer research - and it is easy to read. Audience: This is a must read for those who are about to enter the field of translational research in prostate cancer, but it also serves as an excellent reference for established investigators. Features: The 26 chapters are divided into three parts: basic biology and imaging,genetics, and therapy. In part I, 13 chapters cover topics ranging from prostate cancer stem cells to bone metastasis and from androgen receptor functions to novel molecular signaling events. Of particular interest, the editors have selected practical technologies such as xenograft models, tissue microarrays, nanotechnologies, and modern noninvasive imaging techniques. As pointed out by the editors, in the post-human-genome era, much progress has been made in understanding the genetics of human prostate cancer. The five chapters in part II offer readers the latest information in genetic and epigenetic advances in this area. Part III devotes eight chapters to the most innovative ideas for treating patients with advanced prostate cancer. Although effective therapeutic strategies are not yet available for advanced prostate cancer, the Lance Armstrong effect described by Don Coffey in the foreword fits perfectly for this book. Assessment: It will be interesting to look back, say in 10 years, to see whether these chapters have paved the way for the development of new and efficacious therapeutic procedures for prostate cancer. Score: Weighted Numerical Score: 91 Reviewed by: Chung Lee, Ph.D. ( Northwestern University Feinberg School of Medicine)
Purpose: In aggregate, an attempt is made to adopt the observations of authorities from diverse experience, providing a comprehensive review of the current state of the art on bronchogenic carcinoma. Audience: The audience would include primarily pulmonologists, thoracic surgeons, oncologists, or those aspiring to these disciplines. Others would undoubtedly find the reference selectively informative. It would additionally provide a real-life reference for basic science researchers in putting a face on applications carried out in the laboratory. Features: The book covers the broad subject of bronchogenic carcinoma and augments substantially the presentation of the last edition. Although usually sufficient to carry out the ends of each chapter, the illustrations and graphics are quite limited and probably represent the most notable shortcoming of the book. The bibliographies at each chapter end are extensive and relevant. Assessment: The is one of the most comprehensive and up-to-date treatises that I have surveyed, yet it is remarkably simple and to the point, covering basic molecular biology and genetics underlying the disease for the clinician, as well as epidemiology, early diagnosis, clinical presentation, and management. It focuses exceptionally upon the speculated growing role for targeted therapies with more limited toxicities than historical treatments. The book achieves its likely intended goals well. For an average practitioner, it comes across as very reachable, but probably not a compelling read. I recommend the book highly to anyone in allied disciplines, and would personally consider it a practical resource to add to my personal library.
Lung Cancer, 3rd Edition
Score: Weighted Numerical Score: 88
Editors: Roth, Jack A., MD, FACS; Cox, James D., MD; Hong, Waun Ki, MD, DMSc
Reviewed by: Joel C Seidman, MD ( William Beaumont Hospitals)
© 2009 by the American College of Surgeons Published by Elsevier Inc.
e1
ISSN 1072-7515/09/$36.00 doi:10.1016/j.jamcollsurg.2008.07.014